0001224608-26-000038
SEC filingCNO Financial Group reported first quarter 2026 net income of $37.7 million ($0.39 per diluted share) and net operating income of $101.3 million ($1.05 per diluted share), with operating EPS up 33% year-over-year, driven by strong sales growth, improved insurance product margins, and higher investment income.
CNO’s Q1 2026 results reflect disciplined execution across its diversified middle-market insurance platform, with operating earnings growth (+33% YoY) outpacing GAAP net income (+76% YoY), underscoring the impact of non-operating headwinds—including $15.2M in net investment losses, $7.5M negative market value change, $42.4M decline from embedded derivative fair value adjustments, and $13.7M TechMod expenses. Insurance product margin rose to $256.9M (+2.3% YoY), driven by strength in fixed indexed annuities ($50.2M vs. $44.5M), supplemental health ($71.2M), and long-term care ($38.3M), while Medicare supplement margin softened due to modestly higher claims. Fee income rebounded to $10.6M after a negative $0.8M in Q1 2025, reflecting reclassification of Worksite fee services to non-operating beginning in Q4 2025. Management highlighted 15 consecutive quarters of sales growth, 13th and 15th straight quarters of producing agent count growth in Consumer and Worksite divisions respectively, and record client assets in brokerage/advisory (+27% YoY). The company reaffirmed full-year 2026 guidance—including $4.25–$4.45 Non-GAAP EPS—and reiterated its 200-basis-point operating ROE improvement target through 2027, anchored by sustained sales momentum, disciplined capital allocation ($77M returned to shareholders), and ongoing tech modernization. With statutory RBC at 375%, debt-to-capital at 26.4%, and $280M holding company liquidity, CNO maintains a robust capital position despite near-term investment volatility.